The independent source for health policy research, polling, and news.
421 - 440 of 112,886 Results
According to a study, call volumes nearly doubled after the 2021 approval of semaglutide for the treatment of obesity, rising from roughly 1,000 to 1,500 cases annually to over 8,000 by 2023, HealthDay News reports.
Judge Beryl Howell of the U.S. District Court for the District of Columbia said trade groups and healthcare organizations “are likely to succeed on their [Administrative Procedure Act] claim that the Rule’s definition of ‘professional degree’ is contrary to law.” She also noted that blocking the rule is in the public interest. Plus: Modern Healthcare examines the physician assistant shortage.
Public health experts panned the revised charter — posted to the CDC's website this week — as a way for Health and Human Services Secretary Robert F. Kennedy Jr. to shape his anti-vaccine policy. Under his previously revised charter, a court ruled that ACIP's panelists lacked the qualifications to guide vaccine policy. Plus, a request by military branches to continue vaccinating trainees for the flu went unanswered until June 16, The New York Times reported.
The president has instructed his team to study pesticide use, "prioritize" the approvals of alternatives, and find "creative solutions for evaluating the exposure, diagnosis, and treatments of cumulative chemical exposures on individual health.” MAHA members derided the executive order, with one noting that “Americans ... deserve a clear plan with accountability to reduce unnecessary chemical exposures in our food supply.”
Healthcare leaders warned that elderly care would bear the brunt of the ruling, which lets the Trump administration end temporary protections for more than 350,000 people from Haiti and Syria. At least one Republican, Rep. Mike Lawler of New York, said the ruling "will create a crisis" in healthcare.
Today's early morning highlights from the major news organizations.
Opinion writers discuss these public health issues.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
As the Ebola crisis widens, scientists are set to test two drugs — Gilead Sciences’ antiviral drug remdesivir and MappBio’s monoclonal antibody MBP-134 — to determine whether either is an effective treatment against the disease. The clinical trials will take place in Congo.
Health Committee chairman Bill Cassidy, R-Louisiana, indicated he is open to advancing legislation to limit out-of-pocket costs for diabetes patients but says he wants more information about the measure's impacts from the Congressional Budget Office, Politico reports.
The New York Times reports the shortages were brought on by manufacturing difficulties, shipping delays, and decisions by some companies to stop producing the medications altogether, according to the FDA.
The Trump administration has paused or rescinded grants and contracts it says do not align with the president’s priorities, Bloomberg reported. One expert opposed to the changes said, “To attempt to remake it into a funding stream for conservative ideology ... denies young people the high-quality sexual health education they need and deserve."
One firefighter called it "long, long overdue." The Forest Service has been slow to address the serious health effects of smoke and to enact worker protections, NBC News wrote. Other administration news is on the affordable-housing bill; transgender medical records; deaths at national parks; the worsening flu outbreak at Lackland Air Force Base; and more.
The Centers for Medicare & Medicaid Services Office of the Actuary also expects the U.S. uninsured rate to rise from 8.2% to 9.5% by 2034. Modern Healthcare breaks down the projections.
Today's early morning highlights from the major news organizations.
Editorial writers delve into these public health topics.
Los Angeles public schools approved a resolution to strictly slash screen time for students, with zero screen usage until second grade and tiered limits as they age. Also in the news: Michigan, Missouri, Colorado, Texas, Georgia, and Indiana.
Only three procedures designed to boost fertilization — endometrial scratching, physiological intracytoplasmic sperm injection, and EmbryoGlue — were supported by rigorous studies, researchers found. Scientists think more funding to study the IVF add-ons would be beneficial.
The bipartisan 21st Century Road to Housing Act loosens federal regulations and lending rules, rewards communities that build, delivers aid to communities devastated by disasters, and limits the number of single-family homes institutional investors can own, The New York Times explains. President Donald Trump is expected to enact the measure today, a White House official said.
© 2026 KFF